Cite

    Xu, S., Liu, X., Ming, J., Chen, S., Wang, Y., Liu, X., Liu, H., Peng, Y., Wang, J., Lin, J., Ji, H., Liu, B., Lu, Y., Liu, P., Zhang, Y., & Ji, Q. (2015). a phase 3, multicenter, randomized, allopurinol‐controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia. International journal of rheumatic diseases, 18, 669–678. http://access.bl.uk/ark:/81055/vdc_100071002490.0x000001